Takeda Pharmaceutical Ltd ADR (TAK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TAK | ZTS | ONC | ||
| Company | Takeda Pharmaceutical Ltd ADR | Zoetis Inc Cl A | Beone Medicines Ltd | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | ||
| Open | 18.61 | 126.33 | 355.95 | ||
| High | 18.70 | 128.80 | 363.67 | ||
| Low | 18.52 | 125.60 | 354.36 | ||
| Latest | 18.66 | 128.78 | 362.14 | ||
| Change | unch | +1.50 | +7.66 | ||
| % Change | unch | +1.18% | +2.16% | ||
| Volume | 2,000,700 | 5,799,000 | 195,500 | ||
| 20-Day Average Volume | 3,242,525 | 4,854,055 | 216,090 | ||
| Previous Close | 18.66 | 127.28 | 354.48 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 17.72 | 125.84 | 348.73 | ||
| 20-Day Raw Stochastic | 95.35% | 72.62% | 90.57% | ||
| 20-Day Relative Strength | 76.00 | 54.96 | 59.84 | ||
| Weighted Alpha | +41.32 | -19.97 | +45.97 | ||
| Today's Opinion | 100% Buy | 40% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 40% Sell | 88% Buy | ||
| Last Month's Opinion | 88% Buy | 56% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.58% since 02/12/26 | +2.50% since 02/12/26 | +4.54% since 02/12/26 | ||
| Low | 18.19 on 02/17/26 | 124.50 on 02/18/26 | 345.04 on 02/17/26 | ||
| High | 18.79 on 02/18/26 | 130.65 on 02/13/26 | 365.60 on 02/19/26 | ||
| 1-Month | |||||
| %Chg | +15.54% since 01/20/26 | +4.50% since 01/20/26 | +8.33% since 01/20/26 | ||
| Low | 15.78 on 01/21/26 | 118.94 on 02/12/26 | 328.91 on 02/02/26 | ||
| High | 18.79 on 02/18/26 | 132.49 on 02/12/26 | 365.60 on 02/19/26 | ||
| 3-Month | |||||
| %Chg | +32.72% since 11/20/25 | +11.12% since 11/20/25 | +3.68% since 11/20/25 | ||
| Low | 14.09 on 11/21/25 | 115.59 on 12/09/25 | 299.50 on 12/16/25 | ||
| High | 18.79 on 02/18/26 | 132.49 on 02/12/26 | 365.60 on 02/19/26 | ||
| 6-Month | |||||
| %Chg | +20.54% since 08/20/25 | -17.85% since 08/20/25 | +17.07% since 08/20/25 | ||
| Low | 12.99 on 10/30/25 | 115.25 on 11/19/25 | 295.22 on 08/28/25 | ||
| High | 18.79 on 02/18/26 | 159.00 on 08/21/25 | 385.22 on 11/17/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 59,375,676 | 54,361,640 | 39,713,360 | ||
| Shares Outstanding, K | 3,181,976 | 422,128 | 109,663 | ||
| Annual Sales | 30,238,240,000 | 9,467,000,000 | 3,810,240,000 | ||
| Annual Net Income | 712,320,000 | 2,673,000,000 | -644,790,000 | ||
| Last Quarter Sales | 7,736,500,000 | 2,387,000,000 | 1,412,280,000 | ||
| Last Quarter Net Income | 672,830,000 | 603,000,000 | 124,840,000 | ||
| 60-Month Beta | 0.02 | 0.96 | 0.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.44 on 10/30/25 | 1.48 on 02/12/26 | 1.09 on 11/06/25 | ||
| Latest Earnings Date | 05/14/26 | 05/05/26 | 02/26/26 | ||
| Most Recent Dividend | 0.252 on 09/30/25 | 0.530 on 01/20/26 | N/A | ||
| Next Ex-Dividends Date | 09/30/25 | 04/20/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 11.66 | 19.83 | 206.09 | ||